Company Overview
Hangang Holding Group Co., Ltd. (hereinafter referred to as the "Group"), formerly known as Hangang Real Estate Group Co., Ltd., is a senior real estate developer focusing on the development of second- and third-tier cities in China, headquartered in Hong Kong.
Although the group is mainly engaged in real estate development business, it has been exploring and seeking new opportunities to expand revenue and increase profitability. In an effort to achieve diversified business development of the group, the name of the group was changed from Hangang Real Estate Group Co., Ltd. to Hangang Holding Group Co., Ltd. The Group is actively building a domestic first-class pharmaceutical R&D contract outsourcing service (CRO) platform and has entered the stem cell industry.